• Ways and Means Committee• Indian and Insular Affairs Subcommittee• Health Subcommittee• Veterans' Affairs Committee• Health Subcommittee• Armed Services Committee• Energy and Commerce Committee• Oversight and Government Reform Committee• Natural Resources Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
End Price Gouging for Insulin Act This bill requires the Department of Health and Human Services to set a maximum price for insulin products for individuals and enrollees of federal health programs.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Reform, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee for Indigenous Peoples of the United States.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Reform, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee for Indigenous Peoples of the United States.
AsiaAustraliaCanadaDepartment of Health and Human ServicesEuropeExecutive agency funding and structureFranceGermanyHealth care costs and insuranceHealth programs administration and fundingIndian social and development programsInflation and pricesItalyJapanMedicaidMedical researchMedicareNetherlandsNorth AmericaPrescription drugsResearch administration and fundingResearch and developmentRetail and wholesale tradesSpainSwedenSwitzerlandUnited KingdomVeterans' medical care
End Price Gouging for Insulin Act
USA116th CongressHR-5364| House
| Updated: 1/14/2020
End Price Gouging for Insulin Act This bill requires the Department of Health and Human Services to set a maximum price for insulin products for individuals and enrollees of federal health programs.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Reform, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee for Indigenous Peoples of the United States.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Reform, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee for Indigenous Peoples of the United States.
• Ways and Means Committee• Indian and Insular Affairs Subcommittee• Health Subcommittee• Veterans' Affairs Committee• Health Subcommittee• Armed Services Committee• Energy and Commerce Committee• Oversight and Government Reform Committee• Natural Resources Committee
AsiaAustraliaCanadaDepartment of Health and Human ServicesEuropeExecutive agency funding and structureFranceGermanyHealth care costs and insuranceHealth programs administration and fundingIndian social and development programsInflation and pricesItalyJapanMedicaidMedical researchMedicareNetherlandsNorth AmericaPrescription drugsResearch administration and fundingResearch and developmentRetail and wholesale tradesSpainSwedenSwitzerlandUnited KingdomVeterans' medical care